Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer

NCT06454448 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Adebrelimab (SHR-1316)
Decitabine
Metastatic Pancreatic Cancer

Interventions

DRUG: Adebrelimab;decitabine;

Sponsor

Tianjin Medical University Cancer Institute and Hospital